Plasma microRNA signature associated with retinopathy in patients with type 2 diabetes
Abstract Diabetic retinopathy (DR) is a leading cause of vision loss and disability. Effective management of DR depends on prompt treatment and would benefit from biomarkers for screening and pre-symptomatic detection of retinopathy in diabetic patients. MicroRNAs (miRNAs) are post-transcriptional r...
Main Authors: | Donato Santovito, Lisa Toto, Velia De Nardis, Pamela Marcantonio, Rossella D’Aloisio, Alessandra Mastropasqua, Domenico De Cesare, Marco Bucci, Camilla Paganelli, Lucia Natarelli, Christian Weber, Agostino Consoli, Rodolfo Mastropasqua, Francesco Cipollone |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-02-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-83047-w |
Similar Items
-
Bilateral macular hemorrhage in a patient with COVID-19
by: Rossella D'Aloisio, et al.
Published: (2020-12-01) -
Multiple Therapy Approach for Stage 3 Coats Disease: Long-Term Follow-Up
by: Rodolfo Mastropasqua, et al.
Published: (2020-01-01) -
Retinal vascular metrics difference by comparison of two image acquisition modes using a novel OCT angiography prototype.
by: Luca Di Antonio, et al.
Published: (2020-01-01) -
Epidemiological Surveillance of Eye Disease and People Awareness in the Abruzzo Region, Italy
by: Leonardo Mastropasqua, et al.
Published: (2021-09-01) -
Relationship between aqueous humor cytokine level changes and retinal vascular changes after intravitreal aflibercept for diabetic macular edema
by: Rodolfo Mastropasqua, et al.
Published: (2018-11-01)